Cosmo Pharmaceuticals N.V. (SWX:COPN)

Cosmo Pharmaceuticals Ratios and Metrics

Market cap in millions CHF. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 22, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	993	1,022	818	1,003	1,105	1,229
Market Cap Growth	24.91%	24.91%	-18.39%	-9.22%	-10.15%	9.61%
Enterprise Value	867	902	780	962	1,066	1,154
Last Close Price	62.00	61.49	47.80	56.28	59.21	76.72
PE Ratio	8.14	8.18	-	58.91	49.16	-
Forward PE	20.36	7.78	28.23	35.51	63.09	-
PS Ratio	3.97	4.08	9.48	9.94	16.37	18.64
PB Ratio	2.10	2.16	2.18	2.19	2.08	2.84
P/TBV Ratio	3.38	3.48	3.43	14.09	9.52	2.87
P/FCF Ratio	6.70	6.90	45.41	35.34	149.55	128.14
P/OCF Ratio	6.52	6.71	38.72	30.54	84.48	87.48
PEG Ratio	-	1.65	1.65	1.65	1.65	1.65
EV/Sales Ratio	3.46	3.60	9.03	9.54	15.80	17.50
EV/EBITDA Ratio	5.74	5.99	90.38	23.65	57.74	176.12
EV/EBIT Ratio	6.21	6.46	-	34.71	92.64	590.89
EV/FCF Ratio	5.86	6.09	43.26	33.92	144.35	120.31
Debt / Equity Ratio	0.00	0.00	0.01	0.37	0.33	0.42
Debt / EBITDA Ratio	0.01	0.01	0.18	4.14	9.20	24.49
Debt / FCF Ratio	0.01	0.01	0.10	6.05	23.85	18.97
Asset Turnover	0.46	0.46	0.14	0.13	0.09	0.10
Inventory Turnover	3.27	3.27	3.06	3.29	3.50	4.66
Quick Ratio	3.39	3.39	3.22	1.45	11.77	11.06
Current Ratio	4.19	4.19	4.07	1.57	12.99	11.60
Return on Equity (ROE)	29.31%	29.31%	-2.47%	3.58%	4.75%	-1.99%
Return on Assets (ROA)	15.87%	15.87%	-0.18%	2.24%	0.99%	0.19%
Return on Capital (ROIC)	20.39%	20.39%	-0.22%	2.66%	1.11%	0.20%
Return on Capital Employed (ROCE)	24.90%	24.90%	-	5.00%	1.40%	0.30%
Earnings Yield	12.59%	12.23%	-1.23%	1.70%	2.03%	-0.70%
FCF Yield	14.92%	14.49%	2.20%	2.83%	0.67%	0.78%
Dividend Yield	3.09%	3.13%	3.90%	1.84%	1.66%	-
Payout Ratio	24.09%	24.09%	-	90.61%	-	-
Buyback Yield / Dilution	-1.94%	-1.94%	1.95%	2.83%	-16.81%	1.11%
Total Shareholder Return	1.18%	1.19%	5.85%	4.68%	-15.15%	1.11%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.